05th May, 2026 In a decisive move reinforcing India’s drug regulatory framework, the Delhi High Court has delivered a significant judgment that could reshape how pharmaceutical companies approach approvals—especially for Fixed Dose Combinations (FDCs) and other “new drugs.” The ruling…
- vaayath vaayath
- one Comment.
- Pharma Blog
March 21, 2025 Central Drugs Standard Control Organization, Government of India has been mandated to ensure that the drugs being manufactured and imported into the country meet the standards of quality, safety and efficacy. This has led to the Government…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
